Reliable nucleotide, indel, and structural variant detection in diverse populations
In this PacBio Virtual Global Summit 2020 presentation, Shawn Levy of Discovery Life Sciences shares work on how the ability to reliably detect and characterize the spectrum of sequence variants observed in the human genome is critical for understanding the role of mutation and variation in genetic risk and phenotype. Levy describes how scaled CCS analysis on the Sequel II System supports efficient and reliable detection of complex and simple variants in diverse populations with high accuracy.
Learn more about PacBio at https://pacb.com/
Legal & Trademarks: Visit https://www.pacb.com/legal-and-tradem..."
